Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:421 (19 February), doi:10.1136/bmj.330.7488.421
| The first 150 words of the full text of this article appear below. |
EDITORThree issues raised by Abbasi in his editorial on the recently concluded Ministerial Summit on Health Research in Mexico deserve comment.1
Firstly, Abbasi laments the lack of translatable actions but did not mention additional action items. These were related to a call to donors for more substantive support for health systems research, a call to governments to allocate a certain percentage of national health expenditures to research, and a call to work more closely with countries to use evidence better in health decision making.
Secondly, he was critical of the Mexico agenda, which he states was "drafted largely by representatives of the rich." It should be pointed out that the development of the agenda was informed by wide ranging consultations and meetings in all WHO regions which involved researchers, policy makers, and non-governmental organisations. Ultimately, the agenda will be discussed at the governing bodies of the WHO where
Tikki Pang, director, research policy and cooperation
World Health Organization, 1211 Geneva 27, Switzerland pangt@who.int